Law360, New York (June 28, 2011) — A Pennsylvania federal judge on Monday approved a settlement between a class of college enrollment counselors and Apollo
In Medicine, New Isn’t Always Improved
It is an American impulse to covet the new and improved — whether it’s a faster computer, a smarter cellphone or a more fuel-efficient car.
Takeda, Glaxo Diabetes Treatments Raise Risk of Eye Disease
Takeda Pharmaceutical Co.’s Actos, the world’s best-selling diabetes treatment, and GlaxoSmithKline Plc. (GSK)’s Avandia raise the risk of an eye disease that can lead to
Settlement reached in FirstDIBZ class action lawsuit
The Ticket Reserve, Inc. (TTR), the parent company of ticket options seller FirstDIBZ, has reached a settlement with 752 members of a class action lawsuit
Pfizer’s Bid to Appeal $58 Million Prempro Jury Award Denied
The U.S. Supreme Court refused to hear a Pfizer Inc. (PFE) unit’s appeal of a $58 million award to three Nevada women who contracted breast
5-alpha reductase inhibitors (5-ARIs): Label Change – Increased Risk of Prostate Cancer
AUDIENCE: Urology, Family Medicine, Internal Medicine ISSUE: FDA notified healthcare professionals that the Warnings and Precautions section of the labels for the 5-alpha reductase inhibitor
